Panagora Asset Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-49,119
| Closed | -$13K | – | 2827 |
|
|
2019
Q2 | $13K | Hold |
49,119
| – | – | ﹤0.01% | 2366 |
|
|
2019
Q1 | $11K | Sell |
49,119
-28,022
| -36% | -$6.28K | ﹤0.01% | 2357 |
|
|
2018
Q4 | $19K | Buy |
77,141
+12,218
| +19% | +$3.01K | ﹤0.01% | 2233 |
|
|
2018
Q3 | $16K | Buy |
64,923
+25,232
| +64% | +$6.22K | ﹤0.01% | 2259 |
|
|
2018
Q2 | $10K | Hold |
39,691
| – | – | ﹤0.01% | 2274 |
|
|
2018
Q1 | $10K | Hold |
39,691
| – | – | ﹤0.01% | 2265 |
|
|
2017
Q4 | $11K | Sell |
39,691
-2,234
| -5% | -$619 | ﹤0.01% | 2223 |
|
|
2017
Q3 | $10K | Sell |
41,925
-9,355
| -18% | -$2.23K | ﹤0.01% | 2238 |
|
|
2017
Q2 | $19K | Hold |
51,280
| – | – | ﹤0.01% | 2297 |
|
|
2017
Q1 | $12K | Hold |
51,280
| – | – | ﹤0.01% | 2253 |
|
|
2016
Q4 | $19K | Hold |
51,280
| – | – | ﹤0.01% | 2235 |
|
|
2016
Q3 | $19K | Buy |
+51,280
| New | +$19K | ﹤0.01% | 2272 |
|
|
2014
Q2 | – | Sell |
-151,905
| Closed | -$156K | – | 2453 |
|
|
2014
Q1 | $156K | Hold |
151,905
| – | – | ﹤0.01% | 1814 |
|
|
2013
Q4 | $176K | Sell |
151,905
-1,900
| -1% | -$2.93K | ﹤0.01% | 1709 |
|
|
2013
Q3 | $258K | Sell |
153,805
-21,862
| -12% | -$40.5K | ﹤0.01% | 1565 |
|
|
2013
Q2 | $349K | Buy |
+175,667
| New | +$514K | ﹤0.01% | 1430 |
|
Panagora Asset Management's ENZN Position: Q3 2019 in Review
Panagora Asset Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2019, closing a stake of 49,119 shares — an estimated $13K sold.
Panagora Asset Management first reported a position in ENZN in Q2 2013 and held it in 16 quarters. The position peaked at $349K in Q2 2013. 0 funds tracked by Wall St. Rank hold ENZN as of Q3 2019.
- Panagora Asset Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2019 after selling out during the quarter.
- Panagora Asset Management sold 49,119 ENZON PHARMACEUTICALS INC shares in Q3 2019, an estimated $13K.
- Panagora Asset Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 16 quarters.
- Panagora Asset Management's ENZON PHARMACEUTICALS INC position peaked at $349K in Q2 2013.
- 0 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2019.
Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.